nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—GABRB2—schizophrenia	0.722	1	CbGaD
Etomidate—SLC2A1—blood plasma—schizophrenia	0.00863	0.0977	CbGeAlD
Etomidate—CYP11B2—blood plasma—schizophrenia	0.00739	0.0837	CbGeAlD
Etomidate—SLC2A1—forebrain—schizophrenia	0.00473	0.0535	CbGeAlD
Etomidate—SLC2A1—telencephalon—schizophrenia	0.00435	0.0492	CbGeAlD
Etomidate—SLC2A1—gonad—schizophrenia	0.00363	0.0411	CbGeAlD
Etomidate—SLC2A1—blood—schizophrenia	0.00316	0.0358	CbGeAlD
Etomidate—SLC2A1—midbrain—schizophrenia	0.00312	0.0354	CbGeAlD
Etomidate—SLC2A1—endocrine gland—schizophrenia	0.00274	0.0311	CbGeAlD
Etomidate—CYP11B2—blood—schizophrenia	0.00271	0.0307	CbGeAlD
Etomidate—CYP11B1—blood—schizophrenia	0.00271	0.0307	CbGeAlD
Etomidate—SLC2A1—nervous system—schizophrenia	0.00257	0.0291	CbGeAlD
Etomidate—SLC2A1—central nervous system—schizophrenia	0.00247	0.028	CbGeAlD
Etomidate—SLC2A1—cerebellum—schizophrenia	0.00242	0.0274	CbGeAlD
Etomidate—CYP11B2—endocrine gland—schizophrenia	0.00235	0.0266	CbGeAlD
Etomidate—CYP11B1—endocrine gland—schizophrenia	0.00235	0.0266	CbGeAlD
Etomidate—SLC2A1—brain—schizophrenia	0.00196	0.0222	CbGeAlD
Etomidate—GABRB2—forebrain—schizophrenia	0.00184	0.0209	CbGeAlD
Etomidate—GABRG2—forebrain—schizophrenia	0.00184	0.0209	CbGeAlD
Etomidate—Pethidine—GRIN2C—schizophrenia	0.00173	0.166	CrCbGaD
Etomidate—GABRB2—telencephalon—schizophrenia	0.0017	0.0192	CbGeAlD
Etomidate—GABRG2—telencephalon—schizophrenia	0.0017	0.0192	CbGeAlD
Etomidate—GABRA1—forebrain—schizophrenia	0.00163	0.0184	CbGeAlD
Etomidate—Pethidine—GRIN2D—schizophrenia	0.00161	0.155	CrCbGaD
Etomidate—GABRA1—telencephalon—schizophrenia	0.0015	0.017	CbGeAlD
Etomidate—CYP19A1—forebrain—schizophrenia	0.0015	0.0169	CbGeAlD
Etomidate—GABRB2—midbrain—schizophrenia	0.00122	0.0138	CbGeAlD
Etomidate—GABRG2—midbrain—schizophrenia	0.00122	0.0138	CbGeAlD
Etomidate—CYP19A1—gonad—schizophrenia	0.00115	0.013	CbGeAlD
Etomidate—Pethidine—GRIN1—schizophrenia	0.00109	0.104	CrCbGaD
Etomidate—GABRA1—midbrain—schizophrenia	0.00108	0.0122	CbGeAlD
Etomidate—GABRB2—nervous system—schizophrenia	0.001	0.0113	CbGeAlD
Etomidate—GABRG2—nervous system—schizophrenia	0.001	0.0113	CbGeAlD
Etomidate—CYP19A1—blood—schizophrenia	0.001	0.0113	CbGeAlD
Etomidate—Ephedrine—SLC18A2—schizophrenia	0.00097	0.0931	CrCbGaD
Etomidate—GABRB2—central nervous system—schizophrenia	0.000964	0.0109	CbGeAlD
Etomidate—GABRG2—central nervous system—schizophrenia	0.000964	0.0109	CbGeAlD
Etomidate—GABRB2—cerebellum—schizophrenia	0.000942	0.0107	CbGeAlD
Etomidate—GABRG2—cerebellum—schizophrenia	0.000942	0.0107	CbGeAlD
Etomidate—GABRA1—nervous system—schizophrenia	0.000884	0.01	CbGeAlD
Etomidate—CYP19A1—endocrine gland—schizophrenia	0.000867	0.00982	CbGeAlD
Etomidate—GABRA1—central nervous system—schizophrenia	0.000851	0.00964	CbGeAlD
Etomidate—Tropicamide—CHRM1—schizophrenia	0.000838	0.0804	CrCbGaD
Etomidate—GABRA1—cerebellum—schizophrenia	0.000832	0.00942	CbGeAlD
Etomidate—CYP19A1—nervous system—schizophrenia	0.000812	0.00919	CbGeAlD
Etomidate—Pethidine—GRIN2A—schizophrenia	0.000786	0.0755	CrCbGaD
Etomidate—CYP19A1—central nervous system—schizophrenia	0.000781	0.00885	CbGeAlD
Etomidate—GABRG2—brain—schizophrenia	0.000765	0.00867	CbGeAlD
Etomidate—GABRB2—brain—schizophrenia	0.000765	0.00867	CbGeAlD
Etomidate—Diethylpropion—SLC6A3—schizophrenia	0.000678	0.0651	CrCbGaD
Etomidate—GABRA1—brain—schizophrenia	0.000676	0.00765	CbGeAlD
Etomidate—Pethidine—GRIN2B—schizophrenia	0.000668	0.0642	CrCbGaD
Etomidate—CYP19A1—brain—schizophrenia	0.00062	0.00702	CbGeAlD
Etomidate—Pseudoephedrine—MAOA—schizophrenia	0.000354	0.034	CrCbGaD
Etomidate—Pethidine—SLC6A3—schizophrenia	0.000316	0.0303	CrCbGaD
Etomidate—Pseudoephedrine—SLC6A3—schizophrenia	0.000305	0.0293	CrCbGaD
Etomidate—Pseudoephedrine—TNF—schizophrenia	0.000283	0.0272	CrCbGaD
Etomidate—Pethidine—SLC6A4—schizophrenia	0.000236	0.0227	CrCbGaD
Etomidate—Pseudoephedrine—SLC6A4—schizophrenia	0.000228	0.0219	CrCbGaD
Etomidate—Pethidine—CYP2D6—schizophrenia	0.000166	0.0159	CrCbGaD
Etomidate—Pseudoephedrine—CYP2D6—schizophrenia	0.00016	0.0154	CrCbGaD
Etomidate—CYP11B2—Metabolism—GAPDH—schizophrenia	6.03e-05	0.000337	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APOA1—schizophrenia	5.99e-05	0.000335	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CLOCK—schizophrenia	5.97e-05	0.000334	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	5.96e-05	0.000333	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PPP3CC—schizophrenia	5.95e-05	0.000332	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TAAR6—schizophrenia	5.95e-05	0.000332	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GRM2—schizophrenia	5.95e-05	0.000332	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—NTS—schizophrenia	5.92e-05	0.000331	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	5.89e-05	0.000329	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR1A—schizophrenia	5.86e-05	0.000328	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ATP2A2—schizophrenia	5.85e-05	0.000327	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ACSL6—schizophrenia	5.82e-05	0.000325	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SLC27A5—schizophrenia	5.82e-05	0.000325	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TPH2—schizophrenia	5.82e-05	0.000325	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CACNB2—schizophrenia	5.82e-05	0.000325	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—FGA—schizophrenia	5.79e-05	0.000324	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—NPS—schizophrenia	5.77e-05	0.000323	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC6A1—schizophrenia	5.73e-05	0.00032	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—DPYD—schizophrenia	5.73e-05	0.00032	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	5.69e-05	0.000318	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—DRD1—schizophrenia	5.66e-05	0.000316	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2C—schizophrenia	5.66e-05	0.000316	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ATP2A2—schizophrenia	5.64e-05	0.000315	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—RGS4—schizophrenia	5.57e-05	0.000311	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GRM3—schizophrenia	5.57e-05	0.000311	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—DAO—schizophrenia	5.55e-05	0.00031	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—APOA1—schizophrenia	5.54e-05	0.000309	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NGEF—schizophrenia	5.5e-05	0.000308	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—DRD3—schizophrenia	5.48e-05	0.000306	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR6—schizophrenia	5.47e-05	0.000306	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MTHFR—schizophrenia	5.45e-05	0.000305	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NTS—schizophrenia	5.38e-05	0.000301	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PNP—schizophrenia	5.33e-05	0.000298	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CACNA1C—schizophrenia	5.33e-05	0.000298	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	5.32e-05	0.000297	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—DRD4—schizophrenia	5.32e-05	0.000297	CbGpPWpGaD
Etomidate—SLC2A1—Disease—GSK3B—schizophrenia	5.25e-05	0.000293	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GAPDH—schizophrenia	5.2e-05	0.00029	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PIK3C2A—schizophrenia	5.19e-05	0.00029	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CLOCK—schizophrenia	5.15e-05	0.000288	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	5.14e-05	0.000287	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	5.11e-05	0.000286	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	5.11e-05	0.000286	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CNR1—schizophrenia	5.08e-05	0.000284	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	5.08e-05	0.000284	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOE—schizophrenia	5.08e-05	0.000284	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—RGS4—schizophrenia	5.06e-05	0.000283	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GRM3—schizophrenia	5.06e-05	0.000283	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TPH2—schizophrenia	5.02e-05	0.00028	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CACNB2—schizophrenia	5.02e-05	0.00028	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOA1—schizophrenia	5.02e-05	0.00028	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR6—schizophrenia	4.96e-05	0.000277	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR7—schizophrenia	4.96e-05	0.000277	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—DRD2—schizophrenia	4.96e-05	0.000277	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NDUFV2—schizophrenia	4.95e-05	0.000277	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—DPYD—schizophrenia	4.94e-05	0.000276	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL1B—schizophrenia	4.93e-05	0.000276	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CHRM1—schizophrenia	4.83e-05	0.00027	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—EP300—schizophrenia	4.79e-05	0.000268	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL3RA—schizophrenia	4.71e-05	0.000263	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	4.67e-05	0.000261	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIP4K2A—schizophrenia	4.65e-05	0.00026	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP2D6—schizophrenia	4.65e-05	0.00026	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SNAP25—schizophrenia	4.65e-05	0.00026	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	4.62e-05	0.000258	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CACNA1C—schizophrenia	4.59e-05	0.000256	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	4.56e-05	0.000255	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS1—schizophrenia	4.51e-05	0.000252	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GRM5—schizophrenia	4.49e-05	0.000251	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PIK3C2A—schizophrenia	4.47e-05	0.00025	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—EP300—schizophrenia	4.41e-05	0.000247	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DGKI—schizophrenia	4.4e-05	0.000246	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CHRM1—schizophrenia	4.39e-05	0.000245	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL3RA—schizophrenia	4.27e-05	0.000239	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP26B1—schizophrenia	4.21e-05	0.000235	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP1A2—schizophrenia	4.21e-05	0.000235	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—TH—schizophrenia	4.15e-05	0.000232	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCK—schizophrenia	4.11e-05	0.000229	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ABCB1—schizophrenia	4.09e-05	0.000229	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	4.09e-05	0.000228	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GRM5—schizophrenia	4.08e-05	0.000228	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PPP1R1B—schizophrenia	4.02e-05	0.000225	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SNAP25—schizophrenia	4.01e-05	0.000224	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP2D6—schizophrenia	4.01e-05	0.000224	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PDE4B—schizophrenia	4e-05	0.000224	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCKAR—schizophrenia	3.94e-05	0.00022	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—ADORA2A—schizophrenia	3.82e-05	0.000213	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TPH1—schizophrenia	3.75e-05	0.00021	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GCLM—schizophrenia	3.75e-05	0.00021	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ABCB1—schizophrenia	3.74e-05	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FZD3—schizophrenia	3.74e-05	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCK—schizophrenia	3.73e-05	0.000208	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PDE4B—schizophrenia	3.63e-05	0.000203	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP1A2—schizophrenia	3.63e-05	0.000203	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—schizophrenia	3.58e-05	0.0002	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—TH—schizophrenia	3.58e-05	0.0002	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCKAR—schizophrenia	3.57e-05	0.0002	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—NPY—schizophrenia	3.57e-05	0.000199	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	3.54e-05	0.000198	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PRKD1—schizophrenia	3.53e-05	0.000197	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—COMT—schizophrenia	3.53e-05	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PPP3CC—schizophrenia	3.51e-05	0.000196	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FES—schizophrenia	3.51e-05	0.000196	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM2—schizophrenia	3.51e-05	0.000196	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TAAR6—schizophrenia	3.51e-05	0.000196	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTP1—schizophrenia	3.51e-05	0.000196	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLA2G4A—schizophrenia	3.51e-05	0.000196	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MAOA—schizophrenia	3.5e-05	0.000196	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2A—schizophrenia	3.47e-05	0.000194	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—ADORA2A—schizophrenia	3.47e-05	0.000194	CbGpPWpGaD
Etomidate—SLC2A1—Disease—EP300—schizophrenia	3.45e-05	0.000193	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR1B—schizophrenia	3.44e-05	0.000192	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—OXT—schizophrenia	3.44e-05	0.000192	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—schizophrenia	3.43e-05	0.000192	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	3.4e-05	0.00019	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCB1—schizophrenia	3.32e-05	0.000186	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR1A—schizophrenia	3.31e-05	0.000185	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—YWHAZ—schizophrenia	3.3e-05	0.000184	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—ABCB1—schizophrenia	3.27e-05	0.000183	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—NPS—schizophrenia	3.26e-05	0.000182	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGEF—schizophrenia	3.25e-05	0.000182	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NPY—schizophrenia	3.24e-05	0.000181	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—APOA1—schizophrenia	3.23e-05	0.000181	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PLA2G4A—schizophrenia	3.23e-05	0.00018	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GSTM1—schizophrenia	3.23e-05	0.00018	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD1—schizophrenia	3.2e-05	0.000179	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2C—schizophrenia	3.2e-05	0.000179	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTS—schizophrenia	3.18e-05	0.000178	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—OXT—schizophrenia	3.12e-05	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR1B—schizophrenia	3.12e-05	0.000175	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD3—schizophrenia	3.1e-05	0.000173	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—COMT—schizophrenia	3.04e-05	0.00017	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTP1—schizophrenia	3.03e-05	0.000169	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MAOA—schizophrenia	3.02e-05	0.000169	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR1A—schizophrenia	3.01e-05	0.000168	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD4—schizophrenia	3.01e-05	0.000168	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RGS4—schizophrenia	2.99e-05	0.000167	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RTN4—schizophrenia	2.99e-05	0.000167	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM3—schizophrenia	2.99e-05	0.000167	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NPS—schizophrenia	2.96e-05	0.000166	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—APOA1—schizophrenia	2.96e-05	0.000165	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GAPDH—schizophrenia	2.94e-05	0.000165	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR6—schizophrenia	2.93e-05	0.000164	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.93e-05	0.000164	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CLOCK—schizophrenia	2.92e-05	0.000163	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.91e-05	0.000163	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2C—schizophrenia	2.9e-05	0.000162	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD1—schizophrenia	2.9e-05	0.000162	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—schizophrenia	2.9e-05	0.000162	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—EP300—schizophrenia	2.89e-05	0.000162	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.88e-05	0.000161	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CNR1—schizophrenia	2.87e-05	0.00016	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCB1—schizophrenia	2.86e-05	0.00016	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—APOA1—schizophrenia	2.85e-05	0.000159	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MTHFR—schizophrenia	2.85e-05	0.000159	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TPH2—schizophrenia	2.84e-05	0.000159	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CACNB2—schizophrenia	2.84e-05	0.000159	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAG—schizophrenia	2.83e-05	0.000158	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD3—schizophrenia	2.81e-05	0.000157	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR7—schizophrenia	2.8e-05	0.000157	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—DRD2—schizophrenia	2.8e-05	0.000157	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—DPYD—schizophrenia	2.8e-05	0.000156	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PLA2G4A—schizophrenia	2.78e-05	0.000155	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GSTM1—schizophrenia	2.78e-05	0.000155	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD4—schizophrenia	2.73e-05	0.000153	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—schizophrenia	2.65e-05	0.000148	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOA1—schizophrenia	2.62e-05	0.000147	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CNR1—schizophrenia	2.61e-05	0.000146	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CACNA1C—schizophrenia	2.6e-05	0.000145	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CHRM1—schizophrenia	2.59e-05	0.000145	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—APOA1—schizophrenia	2.58e-05	0.000144	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR7—schizophrenia	2.54e-05	0.000142	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—DRD2—schizophrenia	2.54e-05	0.000142	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PIK3C2A—schizophrenia	2.53e-05	0.000142	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL3RA—schizophrenia	2.52e-05	0.000141	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRG3—schizophrenia	2.46e-05	0.000138	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TLE1—schizophrenia	2.46e-05	0.000138	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—schizophrenia	2.46e-05	0.000137	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GFAP—schizophrenia	2.44e-05	0.000136	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GRM5—schizophrenia	2.41e-05	0.000135	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TLE3—schizophrenia	2.33e-05	0.00013	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOE—schizophrenia	2.29e-05	0.000128	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SNAP25—schizophrenia	2.27e-05	0.000127	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP2D6—schizophrenia	2.27e-05	0.000127	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOA1—schizophrenia	2.26e-05	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCK—schizophrenia	2.2e-05	0.000123	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PDE4B—schizophrenia	2.15e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCKAR—schizophrenia	2.11e-05	0.000118	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—schizophrenia	2.09e-05	0.000117	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP1A2—schizophrenia	2.06e-05	0.000115	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADORA2A—schizophrenia	2.05e-05	0.000114	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TH—schizophrenia	2.03e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PLA2G4A—schizophrenia	2.01e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—FGA—schizophrenia	1.96e-05	0.00011	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2A—schizophrenia	1.96e-05	0.00011	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—schizophrenia	1.93e-05	0.000108	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NPY—schizophrenia	1.91e-05	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH4—schizophrenia	1.91e-05	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ATP2A2—schizophrenia	1.91e-05	0.000107	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—OXT—schizophrenia	1.85e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1B—schizophrenia	1.85e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2A—schizophrenia	1.78e-05	9.96e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR1A—schizophrenia	1.78e-05	9.93e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NPS—schizophrenia	1.75e-05	9.78e-05	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—schizophrenia	1.75e-05	9.77e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—COMT—schizophrenia	1.72e-05	9.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD1—schizophrenia	1.72e-05	9.59e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2C—schizophrenia	1.72e-05	9.59e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTP1—schizophrenia	1.71e-05	9.58e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MAOA—schizophrenia	1.71e-05	9.56e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK2—schizophrenia	1.67e-05	9.33e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD3—schizophrenia	1.66e-05	9.29e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.66e-05	9.27e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—EP300—schizophrenia	1.65e-05	9.19e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCB1—schizophrenia	1.62e-05	9.07e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD4—schizophrenia	1.61e-05	9.02e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLA2G4A—schizophrenia	1.58e-05	8.81e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GSTM1—schizophrenia	1.58e-05	8.81e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CNR1—schizophrenia	1.54e-05	8.61e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—EP300—schizophrenia	1.51e-05	8.45e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR7—schizophrenia	1.5e-05	8.4e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—DRD2—schizophrenia	1.5e-05	8.4e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRL—schizophrenia	1.42e-05	7.93e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—schizophrenia	1.39e-05	7.78e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—S100B—schizophrenia	1.32e-05	7.39e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—EP300—schizophrenia	1.3e-05	7.29e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—schizophrenia	1.3e-05	7.24e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOA1—schizophrenia	1.28e-05	7.16e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB4—schizophrenia	1.27e-05	7.07e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLA2G4A—schizophrenia	1.19e-05	6.65e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—schizophrenia	1.18e-05	6.58e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NRG1—schizophrenia	1.17e-05	6.52e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MEF2C—schizophrenia	1.16e-05	6.47e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—YWHAZ—schizophrenia	1.12e-05	6.25e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ERBB3—schizophrenia	1.09e-05	6.11e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2A—schizophrenia	1.05e-05	5.88e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—schizophrenia	9.94e-06	5.56e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—schizophrenia	9.79e-06	5.47e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOA1—schizophrenia	9.67e-06	5.41e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ESR1—schizophrenia	9.34e-06	5.22e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—schizophrenia	9.14e-06	5.11e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GSK3B—schizophrenia	8.48e-06	4.74e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—schizophrenia	7.88e-06	4.4e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—EP300—schizophrenia	7.39e-06	4.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—schizophrenia	6.28e-06	3.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—schizophrenia	5.71e-06	3.19e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—EP300—schizophrenia	5.58e-06	3.12e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—schizophrenia	4.46e-06	2.49e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—schizophrenia	3.99e-06	2.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—schizophrenia	3.37e-06	1.88e-05	CbGpPWpGaD
